BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 8768828)

  • 41. Growth hormone (GH)-releasing hormone-(1-29) twice daily reverses the decreased GH and insulin-like growth factor-I levels in old men.
    Corpas E; Harman SM; Piñeyro MA; Roberson R; Blackman MR
    J Clin Endocrinol Metab; 1992 Aug; 75(2):530-5. PubMed ID: 1379256
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effects of estradiol and exogenous insulin-like growth factor I (IGF-I) on the IGF-I axis during growth hormone inhibition and antagonism.
    Wilson ME
    J Clin Endocrinol Metab; 1998 Nov; 83(11):4013-21. PubMed ID: 9814485
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Free insulin-like growth factor I serum levels in 1430 healthy children and adults, and its diagnostic value in patients suspected of growth hormone deficiency.
    Juul A; Holm K; Kastrup KW; Pedersen SA; Michaelsen KF; Scheike T; Rasmussen S; Müller J; Skakkebaek NE
    J Clin Endocrinol Metab; 1997 Aug; 82(8):2497-502. PubMed ID: 9253324
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The relationship between 24-hour growth hormone secretion and insulin-like growth factor I in patients with successfully treated acromegaly: impact of surgery or radiotherapy.
    Peacey SR; Toogood AA; Veldhuis JD; Thorner MO; Shalet SM
    J Clin Endocrinol Metab; 2001 Jan; 86(1):259-66. PubMed ID: 11232010
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Free dissociable insulin-like growth factor I (IGF-I), total IGF-I and their binding proteins in girls with Turner syndrome during long-term growth hormone treatment.
    Bannink EM; van Doorn J; Stijnen T; Drop SL; de Muinck Keizer-Schrama SM
    Clin Endocrinol (Oxf); 2006 Sep; 65(3):310-9. PubMed ID: 16918949
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Circadian variation in serum free ultrafiltrable insulin-like growth factor I concentrations in healthy children.
    Heuck C; Skjaerbaek C; Orskov H; Wolthers OD
    Pediatr Res; 1999 May; 45(5 Pt 1):733-6. PubMed ID: 10231873
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Serum insulin-like growth factor I (IGF-I), IGF-binding protein-1 and -3, and the acid-labile subunit as serum markers of body composition during growth hormone (GH) therapy in adults with GH deficiency.
    Thorén M; Hilding A; Baxter RC; Degerblad M; Wivall-Helleryd IL; Hall K
    J Clin Endocrinol Metab; 1997 Jan; 82(1):223-8. PubMed ID: 8989263
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pharmacodynamic hormonal effects of anamorelin, a novel oral ghrelin mimetic and growth hormone secretagogue in healthy volunteers.
    Garcia JM; Polvino WJ
    Growth Horm IGF Res; 2009 Jun; 19(3):267-73. PubMed ID: 19196529
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Nutritional and endocrine-metabolic aberrations in amenorrheic athletes.
    Laughlin GA; Yen SS
    J Clin Endocrinol Metab; 1996 Dec; 81(12):4301-9. PubMed ID: 8954031
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effects of season and nutrition on growth hormone and insulin-like growth factor-I in male red deer.
    Webster JR; Corson ID; Littlejohn RP; Stuart SK; Suttie JM
    Endocrinology; 1996 Feb; 137(2):698-704. PubMed ID: 8593820
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The chronic oral administration of arginine aspartate decreases secretion of IGF-1 and IGFBP-3 in healthy volunteers.
    Blazejewski S; Georges A; Forest K; Corcuff JB; Abouelfath A; Girodet PO; Kamagate M; Jacquet A; Pillet O; Bordenave L; Moore N
    Fundam Clin Pharmacol; 2009 Jun; 23(3):339-44. PubMed ID: 19527301
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effects of androgen administration on the growth hormone-insulin-like growth factor I axis in men with acquired immunodeficiency syndrome wasting.
    Grinspoon S; Corcoran C; Stanley T; Katznelson L; Klibanski A
    J Clin Endocrinol Metab; 1998 Dec; 83(12):4251-6. PubMed ID: 9851759
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Peak and trough growth hormone concentrations have different associations with the insulin-like growth factor axis, body composition, and metabolic parameters.
    Hindmarsh PC; Fall CH; Pringle PJ; Osmond C; Brook CG
    J Clin Endocrinol Metab; 1997 Jul; 82(7):2172-6. PubMed ID: 9215290
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effects of an oral ghrelin mimetic on body composition and clinical outcomes in healthy older adults: a randomized trial.
    Nass R; Pezzoli SS; Oliveri MC; Patrie JT; Harrell FE; Clasey JL; Heymsfield SB; Bach MA; Vance ML; Thorner MO
    Ann Intern Med; 2008 Nov; 149(9):601-11. PubMed ID: 18981485
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Changes in total ghrelin within the somatotropic axis in severe burn patients: comparison of those with inhalation injury and those without inhalation injury.
    Lee BW; Park SH; Ihm SH; Kim JH; Kim DH; You KC; Kim SW; Yoo HJ
    Growth Horm IGF Res; 2008 Aug; 18(4):291-7. PubMed ID: 18178497
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Insulin, somatotropic, and luteinizing hormone axes in lean and obese women with polycystic ovary syndrome: common and distinct features.
    Morales AJ; Laughlin GA; Bützow T; Maheshwari H; Baumann G; Yen SS
    J Clin Endocrinol Metab; 1996 Aug; 81(8):2854-64. PubMed ID: 8768842
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Long-term testosterone supplementation augments overnight growth hormone secretion in healthy older men.
    Muniyappa R; Sorkin JD; Veldhuis JD; Harman SM; Münzer T; Bhasin S; Blackman MR
    Am J Physiol Endocrinol Metab; 2007 Sep; 293(3):E769-75. PubMed ID: 17550998
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Design and biological activities of L-163,191 (MK-0677): a potent, orally active growth hormone secretagogue.
    Patchett AA; Nargund RP; Tata JR; Chen MH; Barakat KJ; Johnston DB; Cheng K; Chan WW; Butler B; Hickey G
    Proc Natl Acad Sci U S A; 1995 Jul; 92(15):7001-5. PubMed ID: 7624358
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Oral ghrelin receptor agonist MK-0677 increases serum insulin-like growth factor 1 in hemodialysis patients: a randomized blinded study.
    Campbell GA; Patrie JT; Gaylinn BD; Thorner MO; Bolton WK
    Nephrol Dial Transplant; 2018 Mar; 33(3):523-530. PubMed ID: 28340044
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effects of alternate-day or daily prednisone treatment on GH and cortisol levels in growth-retarded children after renal transplantation.
    Hokken-Koelega AC; de Muinck Keizer-Schrama SM; Drop SL
    J Pediatr Endocrinol; 1994; 7(2):119-25. PubMed ID: 7520318
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.